A novel pattern of mutation in uromodulin disorders:: Autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease

被引:36
|
作者
Lens, XM [1 ]
Banet, JF [1 ]
Outeda, P [1 ]
Barrio-Lucía, V [1 ]
机构
[1] Univ Santiago, Complexo Hosp, Lab 3, Lab Invest Nefrol Planta 0, Santiago De Compostela 15706, Spain
关键词
uromodulin; Tamm-Horsfall protein; medullary cystic kidney disease; familial juvenile hyperuricemic nephropathy; glomerulocystic kidney disease;
D O I
10.1053/j.ajkd.2005.04.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Autosomal dominant medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and autosomal dominant glomerulocystic kidney disease (GCKD) constitute a hereditary renal disease group that may lead to end-stage renal failure caused by mutations of the UMOD gene and its product, uromodulin or Tamm-Horsfall protein. Of 34 different UMOD mutations described to date, 28 were located in exon 4. Based on such mutation clustering, some investigators have proposed that the sequencing of UMOD exon 4 might become a preliminary diagnostic test for patients with this phenotype. Methods: We performed linkage analysis and sequencing of the entire codifying region of the UMOD gene in 4 Spanish families with MCKD/FJHN/GCKD. Results: All families were shown to present mutations in the UMOD gene. In 3 families, the detected mutations were located in exon 5. Although 1 novel mutation (GIn316Pro) was observed in 2 of these families, a previously reported mutation (Cys300Gly) was found in the other kindred. The Cys300Gly mutation was found in the family presenting with a GCKD phenotype. Conclusion: Our data show a novel mutation pattern in UMOD, suggesting that exon 5 mutations can be more frequent in some populations. Our results support that every exon of the UMOD gene must be included in molecular testing and provide additional evidence for the existence of a fourth calcium-binding epidermal growth factor-like domain in the structure of Tamm-Horsfall protein. A second family reported to date is described, confirming that the GCKD phenotype may be caused by a UMOD mutation. (c) 2005 by the National Kidney Foundation, Inc.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [41] Novel Treatments of Autosomal Dominant Polycystic Kidney Disease
    Mahnensmith, Rex L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (05): : 831 - 836
  • [42] Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease
    Schiano, Guglielmo
    Lake, Jennifer
    Mariniello, Marta
    Schaeffer, Celine
    Harvent, Marianne
    Rampoldi, Luca
    Olinger, Eric
    Devuyst, Olivier
    EMBO MOLECULAR MEDICINE, 2023, 15 (12)
  • [43] Treatment of Autosomal Dominant Tubulointerstitial Kidney Disease Uromodulin (ADTKDUMOD) with Antisense Oligonucleotides
    Morgan, Kathy Ye
    Jungels, Nino
    Greer, Christopher
    Garcia, Stephanie
    Thompson, Emily G.
    Jinadasa, Tushare
    Tan, Xuyu
    Adhikari, Kailash
    Guerlavais, Vincent
    Oliver, Ryan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [44] Hereditary cystic kidney diseases: autosomal dominant and autosomal recessive polycystic kidney disease (ADPKD and ARPKD)
    Haumann, Sophie
    Burgmaier, Kathrin
    Bergmann, Carsten
    Mueller, Roman Ulrich
    Liebau, Max C.
    MEDIZINISCHE GENETIK, 2018, 30 (04): : 422 - 428
  • [45] Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
    Kataoka, Hiroshi
    Akagawa, Hiroyuki
    Ushio, Yusuke
    Sato, Masayo
    Manabe, Shun
    Makabe, Shiho
    Kawachi, Keiko
    Akihisa, Taro
    Iwasa, Naomi
    Yoshida, Rie
    Tsuchiya, Ken
    Nitta, Kosaku
    Mochizuki, Toshio
    STROKE-VASCULAR AND INTERVENTIONAL NEUROLOGY, 2022, 2 (05):
  • [46] A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease
    Reddy, Bharathi V.
    Chapman, Arlene B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (10): : 1695 - 1698
  • [47] Cosegregation of bipolar disorder and autosomal-dominant medullary cystic kidney disease in a large family
    Kimmel, RJ
    Kovacs, I
    Vrabel, C
    Wood, B
    Schalling, M
    Kelsoe, JR
    AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (10): : 1972 - 1974
  • [48] Sonographic evaluation of autosomal dominant polycystic kidney disease type 2
    Nicolau, C.
    Torra, R.
    Badenas, C.
    Bianchi, L.
    Gilabert, R.
    Vilana, R.
    Bru, C.
    Ultrasound in Medicine and Biology, 2000, 26 (SUPPL. 2):
  • [49] Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease
    Hopp, Katharina
    Catenacci, Victoria A.
    Dwivedi, Nidhi
    Kline, Timothy L.
    Wang, Wei
    You, Zhiying
    Nguyen, Dustin T.
    Bing, Kristen
    Poudyal, Bhavya
    Johnson, Ginger C.
    Jackman, Matthew R.
    Miller, Marsha
    Steele, Cortney N.
    Serkova, Natalie J.
    MacLean, Paul S.
    Nemenoff, Raphael A.
    Gitomer, Berenice
    Chonchol, Michel
    Nowak, Kristen L.
    ISCIENCE, 2022, 25 (01)
  • [50] Autophagy and Autosomal Dominant Polycystic Kidney Disease
    Oto, Ozgur Akin
    Edelstein, Charles L.
    TURKISH JOURNAL OF NEPHROLOGY, 2023, 32 (01): : 8 - 15